SmPC - Doxycycline Capsules BP 50mg: Change history
View Summary of Product Characteristics (SmPC - Doxycycline Capsules BP 50mg)
Last updated on this site: 08 Apr 2025
IB C.I.2.a - SmPC section 4.8 for the above-listed MA has been updated in line with the reference product Vibramycin-D 100 mg Dispersible Tablets - PL 00057/0188 (MAH: Pfizer Limited), dated March 2024. Consequently the PIL has been updated. Additionally, editorial updates have been made throughout the PIL.
Last updated on this site: 08 Apr 2025
IB C.I.2.a - SmPC section 4.8 for the above-listed MA has been updated in line with the reference product Vibramycin-D 100 mg Dispersible Tablets - PL 00057/0188 (MAH: Pfizer Limited), dated March 2024. Consequently the PIL has been updated. Additionally, editorial updates have been made throughout the PIL.
-
Changes: (Updated: 08 Apr 2025)
IB C.I.2.a - SmPC section 4.8 for the above-listed MA has been updated in line with the reference product Vibramycin-D 100 mg Dispersible Tablets - PL 00057/0188 (MAH: Pfizer Limited), dated March 2024. Consequently the PIL has been updated. Additionally, editorial updates have been made throughout the PIL.
-
Changes: (Updated: 26 Nov 2024)
To register updates to section 5.1 of the SPC in line with the EMA request to add new text regarding EUCAST breakpoint data.
-
Changes: (Updated: 17 Aug 2023)
To register section 3.2.P.7 Container Closure System for the 20μ Aluminium/250μ PVC blister packaging. There are also updates to section 6.5 of the SmPC (removal of reference to the heat seal lacquer). The label and leaflet are unaffected by this variation.
-
Changes: (Updated: 20 Sep 2022)
Initial upload